Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 8th Edition. Wiley-Springer; 2016. 272 p.
Principles of Cancer Staging. AJCC American Joint Committee on Cancer; [cited 2019 03 15]. Available at: https://facs.groupdropbox.com/share/ac03e57b3ea913ab7d728f5a9f621e84/download?file_ids[]=13911553.
TNM Classification Help (Manual for Cancer Staging); [cited 2019 10 04]. Available at: http://cancerstaging.blogspot.com/.
Organisation: Atomica Informatics
Email: heather.leslie@atomicainformatics.com
Date originally authored: 2016-08-26
Organisation: Atomica Informatics
Email: heather.leslie@atomicainformatics.com
Date originally authored: 2016-08-26
- Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.
- Custodian Organisation: Ocean Informatics
- References: Derived from:
Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 8th Edition. Wiley-Springer; 2016. 272 p. Principles of Cancer Staging. AJCC American Joint Committee on Cancer; [cited 2019 03 15]. Available at: https://facs.groupdropbox.com/share/ac03e57b3ea913ab7d728f5a9f621e84/download?file_ids[]=13911553. TNM Classification Help (Manual for Cancer Staging); [cited 2019 10 04]. Available at: http://cancerstaging.blogspot.com/. - Current Contact: Heather Leslie, Atomica Informatics, heather.leslie@atomicainformatics.com
- Original Namespace: com.oceaninformatics
- Original Publisher: Ocean Informatics
- Custodian Namespace: com.oceaninformatics
- MD5-CAM-1.0.1: E4E54000EC916CD35F579661EDE75874
- Build Uid: 21bc5581-bce6-4db8-b730-e6dd7221a48a
- Revision: 0.0.1-alpha
For example: stomach; or small intestine.
For example: cardia, fundus, corpus, antrum and pylorus (stomach); or duodenum, jejunum or ileum (small intestine).
Designated as 'pT'. Coding with a T code appropriate for the tumour type and anatomical site is expected. For example: 'pT1'; or 'pT3'.
Designated as 'pN'. Coding with an N code appropriate for the tumour type and anatomical site is expected. For example: 'pNX'; or 'pN2'.
Designated as 'pM'. Coding with an M code appropriate for the tumour type and anatomical site is expected. For example: 'pM1'.
Pretreatment histopathological assessment may be determined from a limited biopsy prior to formal resection. Coding with a G code appropriate for the identified tumour type and anatomical site is expected. For example: 'G2'; 'GX'; or 'low grade' for bone and soft tissue sarcoma classification.
For example: 'R2 (Macroscopic residual tumour)'.
- RX [Presence of residual tumour cannot be assessed.]
- R0 [No residual tumour.]
- R1 [Microscopic residual tumour.]
- R2 [Macroscopic residual tumour.]
For example: 'L0 (No lymphatic invasion)'.
- LX [Lymphatic invasion cannot be assessed.]
- L0 [No lymphatic invasion.]
- L1 [Lymphatic invasion.]
For example: 'V1 (Microscopic venous invasion)'.
- VX [Venous invasion cannot be assessed.]
- V0 [No venous invasion.]
- V1 [Microscopic venous invasion.]
- V2 [Macroscopic venous invasion.]
For example: 'Pn0 (No perineural invasion)'.
- PnX [Perineural invasion cannot be assessed.]
- Pn0 [No perineural invasion.]
- Pn1 [Perineural invasion.]
Record only if true, designated by addition of the suffix 'sn'. For example: 'pN0(sn) No sentinel lymph node metastasis' or 'pN1(sn) Sentinel lymph node metastasis'.
Allowed values: {true}
Record only if true, designated by addition of the suffix 'mi'. For example: 'pN1(mi)'.
Allowed values: {true}
For example 'pN0(i-) No regional lymph node metastasis histologically, negative morphological findings for ITC'; 'pN0(mol+) No regional lymph node metastasis histologically, positive non morphological findings for ITC'; or 'pN0(i+)(sn) No sentinel lymph node metastasis histologically, positive morphological findings for ITC'.
- i- [Negative morphological findings for ITC.]
- i+ [Positive morphological findings for ITC.]
- mol- [Negative non-morphological findings for ITC.]
- mol+ [Positive non-morphological findings for ITC.]
For example: 'pM0(i+)' or 'pM0(mol+)'.
- i- [Negative morphological findings for ITC.]
- i+ [Positive morphological findings for ITC.]
- mol- [Negative non-morphological findings for ITC.]
- mol+ [Positive non-morphological findings for ITC.]
Designated as a suffix, either as the letter 'm' or the number of primary tumours. For example: 'pT2(m)' or 'pT2(4)'.
Choice of:
Count
Boolean
Record as true, designated by addition of the prefix 'y'. For example: 'yTNM'.
Allowed values: {true}
Record as true, designated by addition of the prefix 'r'.
Allowed values: {true}
Record as true, designated by addition of the prefix 'a'.
Allowed values: {true}
Record as true, designated by addition of the suffix 'is'. For example: 'pT3(m, is)' or 'pT2(3, is)' or 'pT2(is)'.
Allowed values: {true}
For example: carcinoma in situ is categorised as stage 0; or tumours with distant metastasis are categorised as stage IV.
Silje Ljosland Bakke, Nasjonal IKT HF, Norway (openEHR Editor)
Hildegard Franke, freshEHR Clinical Informatics Ltd. UK
Sergey Kovalenko, Chelyabinsk Regional Children Hospital, Russia
Sabine Leh, Haukeland University Hospital, Department of Pathology, Norway (openEHR Editor)
Miha Lenic, Marand, Slovenia
Heather Leslie, Atomica Informatics, Australia (openEHR Editor)
Ian McNicoll, freshEHR Clinical Informatics Ltd. UK
SARA PRETE, Abinsula, Italy
Natalia Strauch, Medizinische Hochschule Hannover, Germany
Norwegian Review Summary, Nasjonal IKT HF, Norway
John Tore Valand, Helse Bergen, Norway (openEHR Editor)
- German: Natalia Strauch, Medizinische Hochschule Hannover, Strauch.Natalia@mh-hannover.de
- Norwegian Bokmal: Vebjørn Arntzen / Sabine Leh, Oslo University Hospital HF / Helse Bergen HF, varntzen@ous-hf.no